Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2011-05-10

Original market date: See footnote 1

1996-02-02

Product name:

RENAMIN (AMINO ACIDS) INJECTION

DIN:

02020564 Electronic product monograph is not available

Company:

BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

15

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

40:20.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05BA01 AMINO ACIDS

Active ingredient group (AIG) number:See footnote5

1550855001

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
GLYCINE 300 MG / 100 ML
HISTIDINE 420 MG / 100 ML
L-ALANINE 560 MG / 100 ML
L-ARGININE 630 MG / 100 ML
L-ISOLEUCINE 500 MG / 100 ML
L-LEUCINE 600 MG / 100 ML
L-LYSINE HYDROCHLORIDE 450 MG / 100 ML
L-PHENYLALANINE 490 MG / 100 ML
L-PROLINE 350 MG / 100 ML
L-THREONINE 380 MG / 100 ML
L-TYROSINE 40 MG / 100 ML
L-VALINE 820 MG / 100 ML
METHIONINE 500 MG / 100 ML
SERINE 300 MG / 100 ML
TRYPTOPHAN 160 MG / 100 ML
Version 4.0.3

"Page details"

Date modified: